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IntroductIon
In metazoans, mature cells develop from multipotent pro-
genitor cells, a process that requires activation of cell type–
specific gene expression programs alongside repression 
of programs associated with other cell lineages. Gene ex-
pression is linked to the state of the associated chromatin, 
including how accessible enhancers and promoters are to 
the binding of transcription factors and the general tran-
scription machinery. Chromatin accessibility is regulated 
by multiprotein chromatin remodeling complexes (CRCs), 
which control nucleosome position. CRCs are essential for 
normal differentiation of progenitors during development, 
but the mechanisms by which specific CRCs regulate chro-
matin accessibility and lineage fate decisions in multipotent 
progenitors remain poorly understood (Ho and Crabtree, 
2010; Chen and Dent, 2014).
The differentiation of mammalian B and T lympho-
cytes is a powerful model system to study the cellular and 
molecular events that control multilineage differentiation. 
B and T lymphocytes are derived from hematopoietic stem 
cells (HSCs) in the bone marrow that have the ability to 
self-renew and the potential to differentiate into all blood 
cell lineages. During lymphopoiesis, HSCs first differentiate 
into lymphoid-primed multipotent progenitors (LMPPs). 
LMPPs retain the ability to form myeloid and lymphoid cells 
but lack megakaryocyte and erythroid potential (Adolfsson 
et al., 2005). LMPPs subsequently differentiate into common 
lymphoid progenitors, which have minimal ability to differ-
entiate into myeloid cells. The expression of the cell surface 
protein Ly6D has recently been used to separate the hetero-
geneous common lymphoid progenitor population into the 
Ly6D– all-lymphoid progenitor (ALP) subpopulation, which 
retains both B and T cell potential, and the Ly6D+ B cell–
biased lymphoid progenitor (BLP) subpopulation. BLPs are 
derived from ALPs and subsequently give rise to B lineage 
cells (Inlay et al., 2009).
differentiation of lineage-committed cells from multipotent progenitors requires the establishment of accessible chromatin at 
lineage-specific transcriptional enhancers and promoters, which is mediated by pioneer transcription factors that recruit ac-
tivating chromatin remodeling complexes. Here we show that the Mbd3/nucleosome remodeling and deacetylation (nurd) 
chromatin remodeling complex opposes this transcriptional pioneering during B cell programming of multipotent lymphoid 
progenitors by restricting chromatin accessibility at B cell enhancers and promoters. Mbd3/nurd-deficient lymphoid progen-
itors therefore prematurely activate a B cell transcriptional program and are biased toward overproduction of pro–B cells at 
the expense of t cell progenitors. the striking reduction in early thymic t cell progenitors results in compensatory hyperpro-
liferation of immature thymocytes and development of t cell lymphoma. our results reveal that Mbd3/nurd can regulate 
multilineage differentiation by constraining the activation of dormant lineage-specific enhancers and promoters. In this way, 
Mbd3/nurd protects the multipotency of lymphoid progenitors, preventing B cell–programming transcription factors from 
prematurely enacting lineage commitment. Mbd3/nurd therefore controls the fate of lymphoid progenitors, ensuring appro-
priate production of lineage-committed progeny and suppressing tumor formation.
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To produce T cells, ALPs that express the CC-chemokine 
receptors Ccr7 and Ccr9 and P-selectin glycoprotein ligand 
1 (encoded by the gene Selplg) migrate to the thymus (Rossi 
et al., 2005; Inlay et al., 2009; Serwold et al., 2009; Schlenner 
et al., 2010; Zlotoff et al., 2010). Notch1 signaling is then 
activated in these progenitors by Delta-like protein 4(Dll4) 
on thymic stromal cells. This results in expression of tran-
scription factors essential for T cell lineage commitment, 
including Hes1, and rapid loss of B cell lineage potential 
(Ceredig et al., 2007).
For the production of B cells, ALPs in the bone marrow 
first differentiate into BLPs, which requires expression of the 
E2A transcription factor (encoded by Tcf3; Inlay et al., 2009). 
E2A up-regulates the levels of the B cell–specifying pioneer 
transcription factor Ebf1. Ebf1, in association with the SWI/
SNF CRC Brg1/BAF (Brg1-associated factors), induces the 
accessibility of chromatin at B cell lineage-specific enhancers 
and promoters (Bossen et al., 2015; Boller et al., 2016). Ebf1 
also activates expression of Pax5, and these both then act with 
Foxo1 in a positive feedback loop (Mansson et al., 2012). Ex-
pression of these transcription factors results in commitment 
to the B cell lineage (Nutt et al., 1997; Ungerbäck et al., 2015).
Mbd3/nucleosome remodeling and deacetylation 
(Mbd3/NuRD) is a ubiquitously expressed CRC that con-
tains the nucleosome-remodeling ATPase Chd4, a histone 
deacetylase (either Hdac1 or Hdac2), and several accessory 
proteins (Reynolds et al., 2013). Mbd3/NuRD has long been 
accepted as a transcriptional repressor (Ahringer, 2000; Mc-
Donel et al., 2009), but more recent data have shown that 
Mbd3/NuRD is prevalent at enhancers and promoters of ac-
tive gene loci, and the presence of Mbd3/NuRD is as likely 
to be associated with active transcription as repressed tran-
scription (Reynolds et al., 2013; Menafra and Stunnenberg, 
2014; Miller et al., 2016). Mbd3 is a key structural element 
of Mbd3/NuRD, essential for stable assembly of the complex 
(Kaji et al., 2006). In mouse embryos lacking Mbd3, the inner 
cell mass of the blastocyst fails to differentiate into a mature 
epiblast (Kaji et al., 2007). In embryonic stem (ES) cells, 
Mbd3/NuRD at active enhancers and promoters limits ex-
pression of pluripotency-associated genes to enable successful 
lineage commitment and is present during the silencing and 
decommissioning of pluripotency gene enhancers during dif-
ferentiation (Kaji et al., 2006; Reynolds et al., 2012a; Whyte et 
al., 2012; Miller et al., 2016). Because Mbd3-deficient ES cells 
do not undergo lineage-specific differentiation, the mecha-
nisms by which Mbd3/NuRD-mediated chromatin remod-
eling may regulate lineage fate decisions are unclear.
Several Mbd3/NuRD subunit proteins regulate he-
matopoiesis. The Mbd3/NuRD component Mta3 represses 
plasma cell-specific transcription in B cell lines (Fujita et al., 
2004). Loss of Chd4 in HSCs results in erythroid differenti-
ation and exhaustion of the stem cell compartment (Yoshida 
et al., 2008). Chd4 is also required in the thymus for differ-
entiation of β-selected thymocytes and regulation of CD4 
expression (Williams et al., 2004; Naito et al., 2007). Deletion 
of Hdac1 and Hdac2 in differentiating thymocytes prevents 
differentiation beyond the CD4– CD8– stage (Dovey et al., 
2013; Heideman et al., 2013). However, Chd4, Hdac1, and 
Hdac2 each have functions independent from their roles in 
Mbd3/NuRD, so the specific function of the Mbd3/NuRD 
complex in hematopoiesis has remained unknown (Williams 
et al., 2004; Yang and Seto, 2008).
To investigate how chromatin remodeling regulates 
multilineage differentiation, we generated mice with hema-
topoietic cells that lack Mbd3/NuRD. We demonstrate that 
Mbd3/NuRD constrains transcriptional pioneering during B 
cell specification and thus regulates the B versus T cell lineage 
fate of bipotent lymphoid progenitors and prevents the devel-
opment of T cell lymphoma. Our results therefore reveal that 
Mbd3/NuRD chromatin remodeling can protect the multi-
potency of progenitors during differentiation by opposing the 
activation of lineage-specific transcriptional programs.
results
loss of Mbd3 destabilizes the nurd 
complex in hematopoietic cells
To determine the role of Mbd3/NuRD-mediated chroma-
tin remodeling in hematopoiesis, Mbd3Flox/Flox mice (Aguil-
era et al., 2011) were crossed with Vav-cre mice (Stadtfeld 
and Graf, 2005), resulting in pan-hematopoietic deletion. The 
Mbd3 locus in the resulting Mbd3ΔH/ΔH mice showed effi-
cient Cre-mediated recombination throughout all hemato-
poietic organs (Fig. 1 A). Mbd3 mRNA was undetectable in 
Mbd3ΔH/ΔH HSCs, and Mbd3 protein was absent in Mbd3ΔH/ΔH 
bone marrow, spleen, and thymus (Fig. 1, B and C).
Mbd3 is required to maintain the stability of the NuRD 
complex and the abundance of a subset of NuRD compo-
nents in ES cells (Kaji et al., 2006). We found that Mbd3 was 
necessary for the maintenance of normal levels of Chd4 in 
spleen and thymus and Mta2 in bone marrow and thymus 
(Fig. 1 C). Mbd3 was also required to maintain the interaction 
between Chd4 and Hdac1 in the bone marrow (Fig. 1 D). 
These results demonstrate that Mbd3ΔH/ΔH mice lack Mbd3 
expression in hematopoietic cells and that loss of Mbd3 pre-
vents the formation of stable NuRD complexes in these cells.
Mbd3ΔH/ΔH mice develop t cell 
acute lymphoblastic lymphoma
Mbd3ΔH/ΔH mice were born at the expected Mendelian fre-
quency, and the peripheral blood contained cells belonging 
to all hematopoietic lineages (Fig. S1 A). Numbers of periph-
eral blood B and T lymphocytes were reduced in 4-wk-old 
mice but were normal in older mice (Fig. S1 B). As Mbd3ΔH/ΔH 
mice aged, they invariably developed large thymic tumors 
(Fig. 1, E and F). In 29% of cases, enlargement of the spleen 
and peripheral lymph nodes was also detected. Histopatho-
logical analysis showed that the diseased thymi contained a 
population of lymphoblasts with homogeneous morphology, 
loss of medullary and cortical architecture, a high proportion 
of mitotic figures, and numerous tingible body macrophages 
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Figure 1. efficient deletion of Mbd3 in hematopoietic cells of Mbd3ΔH/ΔH mice destabilizes the nurd complex and results in the development of 
t-All. (A) PCR amplification of the Mbd3 locus from genomic DNA isolated from whole bone marrow, thymus, and spleen. Data shown are representative 
of at least three independent experiments using littermate mice. (B) Expression of Mbd3 mRNA in CD150+ CD48– EPCR+ CD45+ HSCs. Measured by quanti-
tative RT-PCR, normalized to the expression of Ubc. Mean ± SE is shown, summarizing three independent experiments using littermate mice. ***, P < 0.005, 
Welch’s t test. (C) Western blots of nuclear extracts, detecting NuRD complex proteins in whole bone marrow, spleen, and thymus. The antibodies used for 
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(Fig. 1 F). These features are characteristic of T cell acute lym-
phoblastic lymphoma (T-ALL).
FACS analysis of Mbd3ΔH/ΔH thymic tumors indicated 
that the majority of cells were CD8a+ CD4– TCRβ– CD24hi 
(Fig. 1 G). This phenotype is identical to that of immature 
single-positive (ISP) T cell progenitors, which arise during 
the transition from CD4– CD8– double-negative to CD4+ 
CD8+ double-positive thymocytes during T cell differentia-
tion. To confirm that the thymic masses were indeed clonal 
tumors and did not reflect hyperplasia of immature thymo-
cytes, we analyzed Dβ1-Jβ1 and Dβ2-Jβ2 rearrangement at the 
TCRβ locus (Fig. 1 H). The majority of cells in the Mbd3ΔH/ΔH 
tumors had a single recombination event, indicating that 
they were clonally derived.
Activating mutations in NOT CH1 are detected in 
>50% of human T-ALLs (Aster et al., 2011). Mutations in 
the coding sequence of Notch1 were detected in 10 of 15 
Mbd3ΔH/ΔH T-ALL tumors, affecting the heterodimerization 
domain or resulting in loss of the PEST domain (Fig. 1 I and 
Fig. S2 A). Such mutations are common in human T-ALL 
and result in hyperactivation of Notch signaling (Aster et al., 
2011). We also detected genomic deletions in the 5′ region of 
Notch1 in 6 Mbd3ΔH/ΔH T-ALLs (5 of which also had Notch1 
coding mutations; Fig. S2 B). These deletions cause alternative 
transcription that increases active intracellular Notch1 levels 
in murine T-ALL (Ashworth et al., 2010). Hyperactivation of 
Notch signaling in Notch1 mutant Mbd3ΔH/ΔH lymphoma 
was confirmed by the up-regulation of Notch target genes 
Hes1, Dtx1, and Myc (Fig. S2 C).
Mbd3/nurd is required to generate normal numbers of 
early t cell progenitors
Predisposition to T-ALL is often associated with defects in 
T cell differentiation (Yui and Rothenberg, 2014). Discrete 
stages of T cell maturation in the thymus can be identified by 
the expression of characteristic cell surface proteins (Fig. 2 A). 
At 8 wk of age, more than 2 mo before the earliest detec-
tion of thymic transformation, no significant differences in T 
cell differentiation were detected between Mbd3Flox/Flox and 
Mbd3+/ΔH thymi, indicating that a single intact allele of Mbd3 
is sufficient for normal T cell differentiation (Fig. 2, C and 
E–G). Thymi from Mbd3ΔH/ΔH mice exhibited a normal cell 
count (Fig. S1 C). However, FACS analysis revealed a marked 
reduction in the numbers of early T cell progenitors, includ-
ing Flt3+ early thymic progenitors (ETPs), which are the most 
immature thymic cells, derived from the progenitors that mi-
grate from the bone marrow to sustain thymopoiesis (Luc et 
al., 2012). The subsequent Flt3– ETP, DN2, DN3, and DN4 
thymic progenitors were also reduced (Fig. 2, B and C). De-
spite this severe deficit in the number of early T cell progen-
itors, Mbd3ΔH/ΔH thymi contained normal numbers of CD4+ 
CD8+ double-positive thymocytes that constitute the major-
ity of the thymus (Fig. 2, D and E) as well as normal numbers 
of mature CD4+ CD8– helper T cells (Fig. 2 D). Moreover, 
Mbd3ΔH/ΔH thymi contained significantly more CD4– CD8+ 
cells as a consequence of drastically increased numbers of ISP 
thymocytes and CD4– CD8+ TCRβint CD24hi cells (Fig. 2, D, 
F, and G). These latter two populations are transitional stages 
between the CD4– CD8– double-negative thymocytes, which 
were drastically reduced, and CD4+ CD8+ double-positive 
thymocytes, which were present in normal numbers.
Our data indicate that Mbd3/NuRD is required to 
maintain the supply of normal numbers of bone marrow–
derived T cell progenitors to the thymus. These residual early 
progenitors undergo compensatory hyperproliferation at the 
ISP stage, thus maintaining normal thymus cellularity. Con-
sistent with this hypothesis, a significantly larger proportion 
of Mbd3ΔH/ΔH ISP thymocytes were actively cycling (Fig. 2, 
H and I). Analysis of TCR gene rearrangement in older mice 
before onset of T-ALL confirmed that the small number of 
Mbd3ΔH/ΔH early T cell progenitors in the thymus retain suf-
ficient function to maintain polyclonal T lymphopoiesis for 
long periods of time (Fig. 2 J).
Mbd3/nurd prevents precocious B cell differentiation of 
B/t-bipotent lymphoid progenitors
The number of lymphoid progenitors in the bone marrow 
capable of seeding the thymus was analyzed by flow cy-
tometry (Fig.  3  A). Deletion of both alleles of Mbd3 had 
no detectable effect on bone marrow cellularity (Fig. S1 D), 
number of HSCs, or number of LMPPs (Fig. 3 B). However, 
compared with littermate controls, Mbd3ΔH/ΔH bone marrow 
protein detection are shown to the right of each blot, and protein size markers (kD) are shown on the left. Data shown are representative of at least three 
independent experiments using littermate mice. (D) Coimmunoprecipitation of Chd4 and Hdac1 from whole–bone marrow nuclear extracts. Antibodies used 
for immunoblotting are shown to the right of each blot, and protein size markers (kD) are shown on the left. All the images in this panel are from the same 
blot, which was first immunoblotted for Hdac1, then stripped and reprobed for Chd4. Several irrelevant lanes between those shown have been omitted. Data 
shown are representative of two independent experiments using littermate mice. (E) Kaplan-Meier survival curve, showing the age at which mice became 
moribund because of thymoma. (F) Enlarged thymus representative of Mbd3ΔH/ΔH tumors, compared with thymus from sex-matched littermate controls 
(left; bar, 1 cm). Representative hematoxylin and eosin–stained sections were photographed at 400× magnification (right). Data are representative of four 
independent experiments using littermate mice. (G) FACS analysis of representative Mbd3ΔH/ΔH thymus tumor, compared with sex-matched littermate 
control. The percentage of cells in each plot that lie within the each gate is shown. Data are representative of three independent experiments analyzing 
six tumor samples and six age- and sex-matched mice from the same mouse colony. (H) Analysis of Dβ1-Jβ1 and Dβ2-Jβ2 rearrangements at the Tcrb locus 
by PCR of genomic DNA from the indicated tissues. Data shown summarize six independent DNA extractions using age- and sex-matched mice from the 
same mouse colony. (I) Schematic diagram of the Notch1 protein, showing the location of mutations detected in Mbd3ΔH/ΔH T-ALL. The color inside each 
arrowhead represents a single T-ALL. Arrowheads with red outlines indicate frameshift and nonsense mutations that disrupt the C terminus of the protein.
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Figure 2. Mbd3/nurd-deficient thymus contains very few early t cell progenitors, but thymocyte numbers are maintained by an expanded 
population of hyperproliferating immature single-positive thymocytes. (A) Schematic diagram showing cell surface antigen expression during key 
stages of thymocyte differentiation. (B) Representative FACS plots of CD4– CD8– double-negative cell subpopulations in Lin– TCRβ– TCRγδ– thymocytes. (C) 
The percentage of thymocytes in each of the CD4– CD8– double-negative subpopulations (mean ± SEM, n = 6). (D) Representative FACS plots showing CD4 
and CD8 expression in thymocytes, as well as TCRβ and CD24 expression in CD4– CD8+ thymocytes. (E) The percentage of thymocytes in the CD4+ CD8+ 
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contained significantly fewer ALPs and BLPs (Fig. 3, B and 
C) and markedly increased numbers of B220+ c-Kit+ B cell 
precursors belonging to Hardy fractions A, B, and C (Fig. 3, 
D and E). Moreover, in Mbd3ΔH/ΔH mice, a larger proportion 
of fraction B and C cells expressed c-Kit (Fig. 3 F), including 
fraction B and C cells with high levels of c-Kit that were 
not present in control bone marrow (Fig. S3). This indicates 
that genes associated with B-lineage commitment, includ-
ing CD19 and BP-1, are expressed before the repression of 
genes, such as Kit, that are normally down-regulated during 
B-lineage differentiation.
Collectively, these findings were compatible with loss 
of Mbd3/NuRD causing early bipotent lymphoid progen-
itors to undergo precocious B cell differentiation, resulting 
in fewer cells with an ALP and BLP phenotype. To test this 
hypothesis, LMPPs and ALPs were isolated by flow cytometry 
and subjected to B cell and T cell differentiation-inducing 
conditions in vitro. No significant differences were found in 
the potential of single Mbd3Flox/Flox and Mbd3ΔH/ΔH LMPPs 
or ALPs to generate B or T cells when placed in appropri-
ate in vitro conditions (Fig. 4, A and B). However, Mbd3ΔH/ΔH 
LMPPs and ALPs consistently differentiated into B220+ 
CD19+ B cells more rapidly than controls (Fig. 4, C–E). This 
effect was most striking in Mbd3ΔH/ΔH ALPs, in which a sub-
stantial proportion of cells were B220+ CD19+ within 3 d of 
culture, whereas even small numbers of B220+ CD19+ cells 
were not present in control ALP cultures until 6 d. During B 
cell differentiation, prepro–B cells first up-regulate B220, then 
pro–B cells express both B220 and CD19 (Rumfelt et al., 
2006). Mbd3ΔH/ΔH ALP cultures contained a lower proportion 
of B220+ CD19– cells during differentiation, consistent with 
the concept that once B cell differentiation begins in these 
cells, it proceeds abnormally rapidly (Fig. 4 F). These results 
demonstrate that Mbd3-null multipotent lymphoid progen-
itors are poised to undergo premature B cell differentiation.
Mbd3ΔH/ΔH LMPPs and ALPs differentiated into T cell 
progenitors in vitro at a normal rate, indicating that the rapid 
differentiation phenomenon is limited to the B cell lineage 
(Fig. 4 G). Mbd3ΔH/ΔH LMPPs and ALPs also express normal 
levels of the Ccr7 and Ccr9 chemokine receptors that mediate 
migration from the bone marrow to the thymus (Fig. 4 H). 
Together these data suggest that Mbd3/NuRD-deficient 
lymphoid progenitors retain the ability to migrate to the thy-
mus and undergo T cell differentiation but are predisposed to 
differentiate rapidly down the B cell lineage.
Mbd3/nurd restrains the B cell commitment-associated 
transcriptional program
To determine whether the propensity of Mbd3ΔH/ΔH ALPs 
to commit prematurely to the B cell lineage was associated 
with dysregulation of lineage-affiliated genes, we measured 
expression levels of 48 genes (Table S1), including B cell, 
T cell, and myeloid lineage-associated genes, transcriptional 
regulators, and NuRD components, in single HSCs, LMPPs, 
ALPs, and BLPs sorted from Mbd3ΔH/ΔH and control mice. A 
subset of Mbd3ΔH/ΔH ALPs displayed an abnormal gene ex-
pression pattern closely resembling BLPs (Fig. 5 A). More-
over, pseudotemporal ordering of cells along a differentiation 
trajectory based on their gene expression profiles revealed 
that Mbd3-null LMPPs and ALPs possessed transcriptional 
states associated with later stages of differentiation (Fig. 5 B; 
and Fig. S4, A and B). Analysis of the genes that correlated 
with differentiation showed that Ebf1, Cd79a, Pax5, and 
Igll1 were expressed in a higher proportion of Mbd3ΔH/ΔH 
ALPs compared with control ALPs (Fig. 5 C; and Fig. S4, C 
and D). Ebf1 is a pioneer transcription factor that instructs 
the B cell programming of lymphoid progenitors (Boller et 
al., 2016). Cd79a, Pax5, and Igll1 are B cell lineage-specific 
Ebf1 targets that should be silent in ALPs (Maier et al., 2004; 
Zandi et al., 2008; Decker et al., 2009). Although the lev-
els of Ebf1 expression were not significantly higher in indi-
vidual Mbd3-null ALPs (Fig. S4 E), single Mbd3ΔH/ΔH ALPs 
frequently coexpressed Ebf1 and its target genes (Fig. 5 D), 
indicating that Mbd3/NuRD chromatin remodeling limits 
the ability of Ebf1 to activate transcription in multipotent 
lymphoid progenitor cells.
To further investigate the transcriptional consequences 
of Mbd3 loss, we performed global transcriptional profil-
ing of HSCs, LMPPs, ALPs, and BLPs by RNA sequencing 
(RNA-seq). Differences in gene expression between cell 
types were much larger than differences caused by Mbd3 de-
letion, indicating that the overall transcriptional identity of 
these cells was not grossly aberrant in the absence of Mbd3/
NuRD (Fig. 6 A; and Tables S5, S6, S7, and S8). However, 
the set of genes up-regulated during the differentiation of 
control ALPs to control BLPs (Fig. 6 B) was expressed at sig-
nificantly higher levels in Mbd3ΔH/ΔH ALPs compared with 
control ALPs (Fig.  6  C). The leading-edge subset of these 
BLP-specific genes that are enriched in Mbd3ΔH/ΔH ALPs 
includes B cell–specific genes such as transcription factors 
(Ebf1, Pou2af1) and components of the preB cell receptor 
double-positive (DP) thymocyte population. Data are shown as the mean percentage of total thymocytes ± SEM; n = 6. (F) The percentage of thymocytes 
in the CD4– CD8+ population. Data are shown as the mean percentage of total thymocytes ± SEM; n = 6. (G) The percentage of thymocytes in the ISP (CD4– 
CD8+ TCR– CD24+), CD8+ Tc (CD4– CD8+ TCR+ CD24–), and CD4– CD8+ TCRint CD24+ populations of CD4– CD8+ single-positive thymocytes. Data are shown 
as the mean percentage of total thymocytes ± SEM; n = 5. Data shown in B–G represent five independent experiments using littermate control mice. (H) 
Representative FACS plots showing Ki-67 expression and DNA content in ISP thymocytes. Cells in the G0, G1, and S/G2/M phases are indicated. (I) The per-
centage of ISP cells in the G0, G1, and S/G2/M phases of the cell cycle (mean ± SEM; n = 4). Data shown in H and I represent two independent experiments 
using littermate control mice. (J) Analysis of Dβ1-Jβ1 and Dβ2-Jβ2 rearrangements at the Tcrb locus by PCR of genomic DNA from thymus. Data from three 
independent DNA isolations are shown, and this is one representative of two independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.005; and ****, P < 
0.001 (Welch’s t test with Benjamini-Hochberg p-value adjustment to correct for multiple testing).
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Figure 3. Mbd3/nurd maintains normal numbers of B/t-bipotent lymphoid progenitor cells and restricts the number of c-Kit+ pro–B cells. 
(A) Schematic diagram showing cell surface antigen expression during key stages of early B cell differentiation. (B) The percentage of nucleated bone mar-
row cells belonging to the following populations: hematopoietic stem cell (HSC; CD150+ CD48– CD45+ EPCR+), lymphoid-primed multipotent progenitor 
(LMPP; Lin– B220– c-Kit+ Sca-1+ Flt3hi IL7Rα–), all-lymphoid progenitor (ALP; Lin– B220– Flt3hi IL7Rα+ Ly6D–), and B-biased lymphoid progenitor (BLP; Lin– 
B220– Flt3hi IL7Rα+ Ly6D+). Mean ± SEM is shown; n = 6 for HSC, n = 5 for LMPP, ALP, and BLP). (C) Representative FACS plots of the ALP and BLP populations 
within Lin– B220– bone marrow cells. (D) Representative FACS plots showing Hardy B cell progenitor fraction A (Fr. A; B220+ NK1.1– Ly6C– CD93+ CD43+ 
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(Cd79a, VpreB1, VpreB2 and Igll1; Fig. 6 D). Notably, the 
mRNA levels of Ly6d are 2.6-fold higher in Mbd3ΔH/ΔH 
ALPs (Fig. 6 D). These results indicate that Mbd3ΔH/ΔH ALPs 
have prematurely up-regulated the B cell transcriptional pro-
gram and are poised to rapidly differentiate into Ly6D+ BLPs.
Furthermore, the expression of the set of 31 genes 
down-regulated during the differentiation of control ALPs to 
BLPs (Fig.  6 B) is significantly higher in Mbd3ΔH/ΔH BLPs 
than control BLPs (Fig. 6 E). These data indicate that in the 
absence of Mbd3/NuRD, differentiation into BLPs occurs de-
spite incomplete silencing of the ALP transcriptional program.
To confirm our results at the single-cell level, RNA-seq 
was performed on single LMPPs, ALPs, and BLPs obtained 
from normal and Mbd3ΔH/ΔH mice. We identified 289 genes 
that were differentially expressed between normal LMPPs 
and BLPs (Table S9). Dimensionality reduction analyses of 
this gene set allowed comparison of the expression patterns 
of lymphoid differentiation-associated genes in individual 
Mbd3Flox/Flox and Mbd3ΔH/ΔH cells (Fig. 6 F). The results iden-
tified a subset of Mbd3ΔH/ΔH ALPs with an aberrant gene ex-
pression pattern more similar to that of BLPs. Further analysis 
of single-cell RNA-seq data identified 90 genes differentially 
expressed in Mbd3ΔH/ΔH ALPs compared with Mbd3Flox/Flox 
ALPs (false discovery rate < 0.05), including up-regulation 
of Ebf1 and its targets Cd79a and Igll1 and down-regulation 
of the T cell receptor signaling kinase Lck (Table S10). This is 
consistent with the higher proportion of individual Mbd3ΔH/ΔH 
ALPs expressing Ebf1 and its target genes detected by single- 
cell quantitative PCR (qPCR; Fig. 5, C and D).
Three independent sets of gene expression data (single- 
cell qPCR, RNA-seq on sorted populations, and single 
cell RNA-seq) therefore demonstrate that Mbd3-null ALPs 
prematurely activate an early B cell transcriptional pro-
gram. The premature activation of B cell–specific genes in 
Mbd3-deficient progenitors is consistent with their propen-
sity to rapidly differentiate into B cells.
Mbd3/nurd restricts chromatin accessibility 
during B cell specification
Mbd3/NuRD regulates gene expression by binding to en-
hancer and promoter chromatin regions and remodeling 
them to make them less accessible to the transcriptional 
machinery (Yildirim et al., 2011). Chromatin accessibil-
ity changes significantly during B cell specification as a 
de novo enhancer and promoter repertoire is established 
(Bossen et al., 2015; Boller et al., 2016). Chromatin at 
these regions is inaccessible in ALPs and is made more 
accessible by transcriptional pioneering during differen-
tiation into pro–B cells (Bossen et al., 2015). We used the 
assay for transposase-accessible chromatin by sequencing 
(ATAC-seq; Buenrostro et al., 2013) to measure chroma-
tin accessibility in lymphoid progenitors from Mbd3ΔH/ΔH 
and control mice. Mbd3-null ALPs, BLPs, and pro–B cells 
all exhibited more accessible chromatin regions compared 
with Mbd3Flox/Flox controls (Fig. 7 A and Table S11). The 
Mbd3ΔH/ΔH-specific accessible regions were most fre-
quently associated with promoters, although an increased 
proportion of intergenic accessible regions associated with 
Mbd3 deletion was observed in pro–B cells (Fig.  7  B). 
The majority (70.6%) of Mbd3ΔH/ΔH-specific accessi-
ble regions in ALPs were also accessible in Mbd3Flox/Flox 
pro–B cells, indicating that Mbd3 deletion causes prema-
ture accessibility of B cell–associated regulatory regions of 
chromatin during lymphoid differentiation (Fig. 7 C). Con-
sistent with this, Gene Ontology analysis revealed that the 
Mbd3ΔH/ΔH-specific accessible regions in BLPs and pro–B 
cells were associated with genes involved in B cell receptor 
signaling and the immune system (Fig. 7 D).
We further analyzed chromatin accessibility at the reper-
toire of enhancers and promoters active in pro–B cells, which 
has previously been determined by p300 chromatin immu-
noprecipitation sequencing (ChIP-seq; Visel et al., 2009; Lin 
et al., 2012). In control cells, the majority of pro–B cell en-
hancer and promoter regions were inaccessible in ALPs and 
BLPs and became accessible at the pro–B cell stage (Fig. 8, 
A and B). Loss of Mbd3/NuRD had no detectable effect on 
the accessibility of most of these regions in ALPs (probably 
because only a small subset of these regions are accessible at 
this stage) but resulted in a dramatic increase of accessibility in 
BLPs and pro–B cells (Fig. 8, A and B). Accessibility of pro-B 
enhancer regions and transcriptional start sites was unaltered 
in thymic T cell progenitors from Mbd3ΔH/ΔH mice, indicat-
ing that Mbd3/NuRD is specifically required in lymphopoi-
esis to regulate chromatin accessibility in the B cell lineage 
(Fig. S5). Analysis of ChIP-seq data for Chd4 in pro–B cells 
(Schwickert et al., 2014) at the same pro–B cell regions shown 
in Fig. 8 A indicated that most pro–B cell enhancer regions 
are bound by this factor, indicating they are directly bound 
by Mbd3/NuRD (Fig. 8 C).
The Brg1/BAF CRC is recruited to chromatin by B 
cell programming transcription factors including Ebf1, where 
it plays a key role in transcriptional pioneering during B cell 
differentiation, promoting nucleosome depletion and initiat-
ing chromatin accessibility (Gao et al., 2009; Bossen et al., 
2015; Boller et al., 2016). By analyzing published ATAC-seq 
profiles (Bossen et al., 2015) from Brg1-null ALPs, BLPs, and 
CD24lo CD19– c-Kit+), fraction B (B220+ NK1.1– Ly6C– CD93+ CD43+ CD24+ CD19+ BP-1–), and fraction C (B220+ NK1.1– Ly6C– CD93+ CD43+ CD24+ CD19+ 
BP-1+) populations of c-Kit+ bone marrow cells. (E) The percentage of nucleated bone marrow cells in the B220+ c-Kit+ population and in Hardy fraction A, 
c-Kit+ fraction B, and c-Kit+ fraction C (mean ± SEM; n = 6). (F) Representative FACS plots showing c-Kit expression in fraction B and fraction C cells. The 
percentage of cells inside the indicated gates is shown. *, P < 0.05; **, P < 0.01; and ***, P < 0.005 (Welch’s t test with Benjamini-Hochberg p-value adjust-
ment to correct for multiple testing). All data shown are from five independent experiments.
 o
n
 O
ctober 3, 2017
jem.rupress.org
D
ow
nloaded from
 
3093JEM Vol. 214, No. 10
pro–B cells at the same set of pro–B cell active enhancers 
and promoters shown in Fig. 8 A, we found that accessibility 
of these sites was lower in Brg1-null pro–B cells (Fig. 8 D). 
Together, these data indicate that Mbd3/NuRD binds to B 
cell–specific enhancers and promoters and provides repressive 
chromatin remodeling activity during the B cell specification 
of lymphoid progenitor cells, which opposes the activating 
activity of the Brg1/BAF complex.
Figure 4. Mbd3 prevents premature B 
lineage commitment of lymphoid progen-
itors. (A) The proportion of single lymphoid 
progenitor cells with B cell potential when 
seeded in OP9 B differentiation co-culture 
conditions. The phenotype of the seeded cell 
is shown above each graph. The color of the 
bars indicates the phenotype of the single 
cell–derived colonies. Mean ± SEM of the pro-
portion of single cells that formed colonies is 
shown; n = 3 independent experiments, each 
with 30 single cells seeded. (B) The proportion 
of single lymphoid progenitor cells with T cell 
potential when seeded in OP9-DL1 T differen-
tiation co-culture conditions. The phenotype 
of the seeded cell is shown above each graph. 
The color of the bars indicates the pheno-
type of the single cell–derived colonies. Mean 
± SEM of the proportion of single cells that 
formed colonies is shown; n = 3 independent 
experiments, each with 20 single cells seeded. 
(C) The percentage of B220+ CD19+ B cells 
in OP9 B differentiation co-cultures seeded 
by 50 ALPs, measured daily from day 2. Data 
are shown as mean ± SEM of the percentage 
of B220+ CD19+ B cells in each culture; n = 
9 (three independent experiments, each with 
three biologically independent cultures). *, P < 
0.05, Welch’s t test, with Benjamini-Hochberg 
p-value adjustment to correct for multiple 
testing. (D) The percentage of B220+ CD19+ 
B cells in OP9 B differentiation co-cultures 
seeded by 50 LMPPs, measured daily from day 
2. Data are shown as mean ± SEM of the per-
centage of B220+ CD19+ B cells in each cul-
ture; n = 9 (three independent experiments, 
each with three biologically independent cul-
tures). *, P < 0.05, Welch’s t test, with Benja-
mini-Hochberg p-value adjustment to correct 
for multiple testing. (E) Representative FACS 
plots of OP9 B differentiation cultures 4 d after 
seeding with 50 ALP cells. The gating of B220+ 
CD19+ B cells is shown. (F) The percentage of 
B220+ CD19– cells in OP9 B differentiation 
co-cultures seeded with 50 ALPs or 50 LMPPs 
after 5 d in culture. Data are shown as mean 
± SEM of the percentage of B220+ CD19+ B 
cells in each culture; n = 9 (three independent 
experiments, each with three biologically in-
dependent cultures). ****, P < 0.001, Welch’s t 
test, with Benjamini-Hochberg p-value adjustment to correct for multiple testing. (G) The percentage of Thy1+ CD25+ T cell progenitors in OP9-DL1 T differ-
entiation co-cultures seeded by 50 ALPs or 50 LMPPs, measured daily from day 2. Data are shown as mean ± SEM of the percentage of Thy1+ CD25+ cells in 
each culture; n = 3 biologically independent cultures. The data shown here are representative of two independent experiments. (H) Expression of Ccr7 and 
Ccr9 mRNA in Mbd3Flox/Flox (black) and Mbd3ΔH/ΔH (red) LMPPs and ALPs. Measured by quantitative RT-PCR, normalized to the expression of Ubc. Mean ± SE 
normalized to the level of expression in ALPs is shown; n = 5. Data are taken from five independent experiments.
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dIscussIon
Lineage commitment of multipotent progenitors requires re-
organization of chromatin accessibility to activate a lineage- 
specific transcriptional program while repressing genes asso-
ciated with other cell fates (Mercer et al., 2011; Whyte et al., 
2012; Lara-Astiaso et al., 2014). Here we demonstrate that 
Mbd3/NuRD constrains B cell specification by limiting 
chromatin accessibility and repressing a B cell transcriptional 
program. In this way, Mbd3/NuRD prevents lymphoid pro-
genitors from precociously undergoing lineage commitment 
and ensures that appropriate numbers of progeny belonging 
to the B and T cell lineages are produced.
t cell progenitor deficiency in the 
Mbd3/nurd-deficient thymus
Mbd3-null LMPPs and ALPs are able to differentiate into T 
cell progenitors in vitro at normal frequency and rate and 
express the chemokine receptors required for thymic migra-
tion. However, they are predisposed to rapidly differentiate 
into B cell lineage-committed progenitors. Our data there-
fore indicate that Mbd3/NuRD-deficient lymphoid progen-
itors retain the ability to seed the thymus with early T cell 
progenitors, but their propensity to prematurely commit to 
the B cell lineage gives them little opportunity to do so. As a 
result, few early T cell progenitors reach the Mbd3-null thy-
Figure 5. Mbd3/nurd prevents the pre-
mature expression of B cell lineage-specific 
ebf1 target genes in single lymphoid pro-
genitors. (A) Diffusion map dimensionality 
reduction analysis of gene expression pat-
terns in single HSCs, LMPPs, ALPs, and BLPs, 
measured by quantitative RT-PCR. Mapping 
was performed on Mbd3Flox/Flox and Mbd3ΔH/ΔH 
cells together, but cells of each genotype are 
depicted in separate plots. The region of the 
plot that contains cells with a gene expression 
pattern specific to control BLPs is indicated. (B) 
Pseudotime trajectory values of single HSCs, 
LMPPs, ALPs, and BLPs. Higher values indicate 
single cells with gene expression patterns as-
sociated with later stages of differentiation. 
Boxes indicate the interquartile range (IQR) of 
the pseudotime trajectory values in each popu-
lation, the horizontal line indicates the median, 
and the vertical lines show the range of values. 
Outlier values more than 1.5 times the IQR 
outside the IQR are indicated by dots. **, P < 
0.01; and ****, P < 0.001 (Wilcoxon rank sum 
test). (C) The percentage of single ALPs in which 
Ebf1, Cd79a, Pax5, and Igll1 gene expression 
was detected. *, P < 0.05; ***, P < 0.005; and 
****, P < 0.001 (Fisher’s exact test). (D) The per-
centage of single ALPs in which combinations 
of Ebf1, Cd79a, Pax5, and Igll1 gene expression 
were coexpressed. Blue boxes indicate that 
gene expression was detected. *, P < 0.05; and 
**, P < 0.01 (Fisher’s exact test). All data in this 
figure are from single cells sorted from litter-
mate mice in three independent experiments.
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Figure 6. Global transcriptome analysis reveals premature expression of B cell lineage commitment genes in Mbd3/nurd-deficient lymphoid 
progenitors. (A) Principal-component analysis of global gene expression in lymphoid progenitors (n = 5). (B) Schematic showing the number of significantly 
differentially expressed genes in Mbd3Flox/Flox BLPs compared with Mbd3Flox/Flox ALPs (false discovery rate < 0.05). (C) Gene set enrichment analysis (GSEA) 
enrichment score curve analyzing the distribution of the set of genes up-regulated during the transition from normal ALPs to BLPs in Mbd3Flox/Flox ALPs 
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mus, but those that do are able to respond appropriately to 
the thymic microenvironment and differentiate to maintain 
polyclonal T lymphopoiesis.
compensatory hyperproliferation of IsP thymocytes 
and initiation of lymphoma
The effects of denying progenitor supply to the thymus have 
recently been studied using mouse models in which a normal 
thymus is transplanted into a recipient that cannot produce 
thymus-colonizing progenitors. In these studies, cells resident 
within the progenitor-deprived donor thymi, which would 
normally be replaced by freshly supplied progenitors, persist 
to sustain thymus-autonomous T cell development in the ab-
sence of ETPs (Martins et al., 2012, 2014; Peaudecerf et al., 
2012). However, the changes to thymocyte cell biology that 
permit persistent, autonomous T cell production are poorly 
understood. Our data reveal that reduced supply of bone 
marrow progenitors to the thymus induces compensatory ex-
pansion and hyperproliferation of ISP thymocytes, and this is 
critical to maintaining normal thymocyte numbers. Previous 
analyses of progenitor-deprived thymi did not detect abnor-
mal thymocyte proliferation but did not investigate the ISP 
population (Martins et al., 2012; Peaudecerf et al., 2012). In 
addition, persisting thymocytes in progenitor-deprived thymi 
give rise to T-ALL with an ISP-like phenotype, but the rea-
son for this susceptibility to malignant transformation is not 
known (Martins et al., 2014). Rapid proliferation results in 
DNA replication stress and genomic instability (Gorgoulis et 
al., 2005; Gaillard et al., 2015), so our results suggest that com-
pensatory hyperproliferation of ISPs in progenitor-deprived 
thymus may cause the accumulation of oncogenic mutations 
and transformation into T-ALL. Compensatory progeni-
tor hyperproliferation could contribute to carcinogenesis in 
other tissues maintained by progenitor cells if early progeni-
tor supply is disrupted.
Mbd3/nurd chromatin remodeling inhibits 
activation of ebf1 target genes
ALPs differentiate through a stage in which they express 
the B cell–specifying pioneer transcription factor Ebf1, but 
Ebf1-target genes are silent, and both B and T cell poten-
tial are retained (Mansson et al., 2010). Lack of cofactors, 
posttranslational regulation of the Ebf1 protein, and the ex-
pression of suppressor proteins have each been proposed to 
inhibit Ebf1-mediated transcription and prevent premature B 
cell commitment in these progenitors, but there is little ev-
idence supporting these mechanisms (Mansson et al., 2010). 
Our data indicate that Mbd3/NuRD inhibits premature Ebf1 
target gene activation in Ebf1-positive lymphoid progenitors 
and delays the commitment of bipotent B/T lymphoid pro-
genitors to the B cell lineage. Although the timing of Ebf1 
target gene activation is altered in Mbd3/NuRD-deficient 
cells, overall gene expression patterns during B cell differ-
entiation are not broadly aberrant. This suggests that Mbd3/
NuRD-mediated chromatin remodeling acts as a barrier that 
delays the transcriptional activation of Ebf1 targets but does 
not control which loci are targeted by Ebf1 binding. This 
is consistent with the ability of Ebf1 to bind its target loci 
even when they are embedded in naive, inaccessible chroma-
tin (Boller et al., 2016).
Mbd3/nurd controls B versus t lineage fate by inhibiting 
the accessibility of B cell–associated chromatin
Chromatin at pro–B cell enhancers and promoters is made 
more accessible during B cell specification, especially during 
the transition from BLP to pro–B cells (Bossen et al., 2015). 
Ebf1 binds its targets in inaccessible chromatin, and recruits 
the Brg1/BAF CRC, which depletes nucleosomes to initi-
ate chromatin accessibility (Gao et al., 2009; Bossen et al., 
2015; Boller et al., 2016). We found that regions that are 
opened during normal B cell differentiation are prematurely 
accessible in Mbd3-null ALPs. We also found that B cell en-
hancer and promoter regions are prematurely accessible in 
Mbd3-null BLPs and more accessible in Mbd3-null pro–B 
cells. These data indicate that Mbd3/NuRD chromatin re-
modeling opposes the ability of B cell programming factors 
to increase chromatin accessibility. The enhanced accessibil-
ity caused by Mbd3 deletion is more pronounced in BLPs 
and pro–B cells than ALPs. This is most likely because only a 
subset of ALPs in the population have so far undergone chro-
matin modeling to increase accessibility and because of the 
higher expression and activity of B cell programming factors 
that activate chromatin in the more differentiated cells (Inlay 
et al., 2009; Bossen et al., 2015).
The concept of Mbd3/NuRD and Brg1/BAF having 
antagonistic effects is consistent with knockdown studies in 
ES cells and also the observation that Brg1 and the Mbd3/
NuRD component Chd4 have opposing effects on Cd79a 
chromatin accessibility and expression (Gao et al., 2009; Yildi-
rim et al., 2011). We propose a model in which the balance of 
compared with Mbd3ΔH/ΔH ALPs. Top: Kolmogorov-Smirnov running enrichment score. Bottom: location of the genes in this set in the list of gene expression 
changes between Mbd3Flox/Flox ALPs and Mbd3ΔH/ΔH ALPs, ranked by fold change. (D) Heat map showing the relative expression of the leading-edge gene 
subset from GSEA of BLP-specific genes in Mbd3Flox/Flox ALPs versus Mbd3ΔH/ΔH ALPs. Left: calculated fold change in expression (log2 transformed); right: 
relative gene expression detected in each sample (gene-normalized z-score). (E) GSEA enrichment score curve analyzing the distribution of the set of genes 
down-regulated during the transition from normal ALPs to BLPs in Mbd3Flox/Flox BLPs compared with Mbd3ΔH/ΔH BLPs. All data in A–E summarize five inde-
pendent experiments sorting cells from sex-matched littermate mice. (F) Diffusion map dimensionality reduction analysis of gene expression in single cells 
measured by RNA-seq. The analysis includes the expression patterns of 289 genes that change significantly during the differentiation of Mbd3Flox/Flox LMPPs 
into BLPs. Mapping was performed on Mbd3Flox/Flox and Mbd3ΔH/ΔH cells together, but cells of each genotype are depicted in separate plots. Data summarize 
two independent experiments sorting cells from sex-matched littermate mice.
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Figure 7. Accessible chromatin regions in Mbd3/nurd-deficient lymphoid progenitors. (A) Number of accessible chromatin regions detected in lym-
phoid progenitor cells by ATAC-seq. The number of regions specific or common to Mbd3Flox/Flox and Mbd3ΔH/ΔH cells of each type is shown. (B) Genomic fea-
tures associated with accessible chromatin regions. Left: the percentage of accessible chromatin regions associated with each genomic feature. Right: the 
distance and direction of accessible chromatin regions relative to the nearest transcriptional start site (TSS). The accessible regions detected in Mbd3Flox/Flox 
cells are shown, as well as those which are detected only in Mbd3ΔH/ΔH cells of the same type. (C) Number of accessible chromatin regions specific or com-
mon to Mbd3ΔH/ΔH ALPs and Mbd3Flox/Flox pro–B cells. (D) Most significant gene sets detected by Gene Ontology analysis of genes associated with accessible 
regions detected in Mbd3ΔH/ΔH BLPs and pro–B cells, but not in corresponding Mbd3Flox/Flox controls. All data are this figure summarizes two independent 
experiments in which cells were sorted from sex-matched littermate mice.
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Mbd3/NuRD and Brg1/BAF chromatin remodeling activi-
ties controls the fate of B/T-bipotent lymphoid progenitors 
by regulating the accessibility of enhancers and promoters as-
sociated with a B cell transcriptional program. In this model, 
a B cell–specifying pioneer transcription factor (e.g., Ebf1) 
recruits Brg1/BAF to latent B cell lineage-specific enhancers 
and promoters, which promotes chromatin accessibility at 
these regions (Gao et al., 2009; Bossen et al., 2015; Boller 
et al., 2016). The repressive chromatin remodeling activity 
of Mbd3/NuRD bound at these sites opposes the activity 
of Brg1/BAF, and thus inhibits their accessibility (Fig.  9). 
Mbd3/NuRD is therefore essential to prevent multipotent 
lymphoid progentitors prematurely activating expression of a 
B cell transcriptional program and committing to the B cell 
lineage. Expression of Brg1 increases significantly during B 
cell specification from the LMPP stage onwards (Bossen et al., 
Figure 8. Mbd3/nurd-mediated chroma-
tin remodeling restricts the accessibility of 
enhancers and promoters activated during 
B cell lineage specification. (A) ATAC-seq 
chromatin accessibility signal in sorted 
Mbd3Flox/Flox and Mbd3ΔH/ΔH lymphoid progen-
itor cells, at 3,741 active enhancer and pro-
moter regions associated with p300 binding 
in WT pro–B cells. Regions are ordered by the 
significance of the p300 signal in pro–B cells. 
Color intensity shows the number of ATAC-seq 
reads per million. (B) Mean ATAC-seq sig-
nal in sorted lymphoid progenitor cells, at 
all regions associated with p300 binding in 
WT pro–B cells (same regions shown in A). 
(C) Chd4 ChIP-seq signals in WT pro–B cells 
at the same regions shown in A. (D) Mean 
ATAC-seq signal in Brg1-deleted and control 
cells, at the same regions shown in A. All data 
in this figure summarize two independent 
experiments in which cells were sorted from 
sex-matched littermate mice.
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2015). This likely explains why Mbd3/NuRD is specifically 
required during hematopoiesis to inhibit B cell differentia-
tion in lymphoid progenitors.
Mbd3/nurd can inhibit lineage commitment of progenitors 
by constraining the accessibility of dormant lineage-specific 
enhancers and promoters
Mbd3/NuRD promotes differentiation and lineage commit-
ment of ES cells in response to appropriate signals, by inhib-
iting and silencing the established pluripotency-associated 
transcriptional program (Reynolds et al., 2012a,b; Whyte et 
al., 2012; Miller et al., 2016). Consistent with this mecha-
nism, we found that Mbd3/NuRD was necessary for the 
complete silencing of ALP-specific genes during their differ-
entiation into BLPs. However our results also reveal a novel 
mechanism by which Mbd3/NuRD chromatin remodeling 
can regulate the differentiation of multipotent cells: by con-
straining the activation of inaccessible chromatin to inhibit 
differentiation. This mechanism is crucially different, as it 
demonstrates that Mbd3/NuRD can act as a barrier to pre-
vent lineage-specific transcription factors from prematurely 
enacting lineage commitment. Therefore, our data demon-
strate that the regulation of multilineage differentiation by 
Mbd3/NuRD is complex, acting differently in different cel-
lular contexts. This is most likely because the outcome of 
reduced chromatin accessibility mediated by Mbd3/NuRD 
is influenced by the current state of the chromatin land-
scape, and the activities of other CRCs and transcription 
factors in the cell. Because Mbd3/NuRD is ubiquitously 
expressed, it is likely that Mbd3/NuRD regulates many cell 
fate decisions during development by the novel mechanism 
we describe here: opposing the transcriptional pioneering 
of dormant enhancers induced by lineage-specific “master 
regulator” transcription factors.
MAterIAls And MetHods
Mice
Vav-Cre (Stadtfeld and Graf, 2005) mice were backcrossed 
twice to C57BL/6 mice, then bred with mice from the 
floxed Mbd3 (Aguilera et al., 2011) mouse line, which had a 
129/Ola genetic background. Mice were housed in specific 
pathogen-free conditions. PCR primers used to identify in-
tact, floxed, and Cre-recombined Mbd3 alleles were 5′-TTG 
GTA CAG ACC AGG TGC AG-3′, 5′-AAT CAG ATC ACT 
TCA GCT CC-3′, and 5′-CGA AAC CAT GAT AAA GTC 
CC-3′. All procedures were performed according to UK 
Home Office regulations.
nuclear protein extraction, 
coimmunoprecipitation, and immunoblots
Whole bone marrow, spleen, and thymus cells were washed 
once with PBS, then lysed in hypotonic lysis buffer (10 mM 
Hepes, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 1 mM DTT, and 
cOmplete protease inhibitors; Roche). After 10 s of vortexing, 
nuclei were pelleted by centrifugation (10,000 g, 1 min), then 
resuspended in nuclear extraction buffer (10 mM Hepes, pH 
7.9, 420 mM NaCl, 10 mM KCl, 1.5 mM MgCl2, 0.1 mM 
EDTA, 12.5% [vol/vol] glycerol, 1 mM DTT, and cOmplete 
protease inhibitors). After 15 min incubation, and homog-
enization by repeatedly passing through a 23-gauge needle, 
insoluble material was pelleted by centrifugation (20,000 g, 
5 min). The supernatant was retained as nuclear extract. For 
immunoblotting, each lane was loaded with 150 µg protein. 
For coimmunoprecipitation, 10 µg anti-Chd4 antibody was 
mixed with 50 µL of protein G Dynabeads (Thermo Fisher 
Scientific) and incubated overnight. After washing the beads 
three times in immunoprecipitation wash buffer (PBS with 
0.02% [vol/vol] Tween-20), 150 µg nuclear extract protein 
was added. After 4 h, beads were then washed five times with 
immunoprecipitation wash buffer. Proteins were eluted from 
beads in SDS-PAGE loading buffer before immunoblot anal-
ysis. Antibodies used are shown in Table S2.
Flow cytometry
Cell suspensions were stained with antibodies shown in Table 
S2. Cell viability was determined by the exclusion of either 
7AAD or DAPI. For Ki-67 analysis, cell surface antigens 
were stained first, then intracellular Ki-67 was stained using 
the BD Fixation/Permeabilization Solution kit (BD Biosci-
ences). Cell sorting was performed using a FAC SAria (BD 
Biosciences); cells with appropriate surface phenotypes were 
first sorted into separate tubes using “enrichment” precision 
mode. These cells were sorted again, and those still deter-
mined to have the appropriate cell surface phenotype were 
Figure 9. opposing activities of Mbd3/nurd and Brg1/
BAF control chromatin accessibility during B cell pro-
gramming of multipotent lymphoid progenitors. Commit-
ment to the B cell lineage requires activation of dormant B 
cell–specific enhancers and promoters, embedded in inacces-
sible chromatin. Pioneering B cell transcription factors (e.g., 
Ebf1) bind to specific sequences in inaccessible chromatin 
and recruit Brg1/BAF, which remodels nucleosomes to make B 
cell–specific enhancers and promoters accessible. The repres-
sive chromatin remodeling activity of Mbd3/NuRD limits the 
accessibility of these regions, preventing premature activa-
tion of a B cell transcriptional program.
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sorted directly into lysis buffer or tissue culture medium using 
“single cell” or “purity” precision mode.
thymocyte clonality analysis
PCR of D-J regions of the Tcrb locus was performed 
using previously described primers (Whitehurst et al., 
1999); D1J1fwd: 5′-ACC TAT GGG AGG GTC CTT TTT 
TGT ATA AAG-3′; D1J2rev: 5′-AGA CTC CTA GAC 
TGC AGA CTC AG-3′; D2J2_fwd: 5′-AAA GCT GTA 
ACA TTG TGG GGA CAG-3′; and D2J2_rev: 5′-CCC 
GGA GAT TCC CTA ACC CTG GTC-3′.
Analysis of mutations in notch1
Genomic DNA was isolated from T-ALL thymomas using 
a DNeasy Mini kit (QIA GEN). To identify point muta-
tions, DNA from five T-ALLs was mixed together, then 
Notch1-coding exons were amplified using primers shown 
in Table S3. PCR products were then mixed together, blunt-
ended, and ligated together. The ligated PCR products were 
sheared by sonication, and sequencing libraries were pre-
pared. Sequencing was performed on an Illumina NextSeq, 
and reads were aligned to the mouse reference genome using 
STAR (Dobin et al., 2013). Potential mutations were iden-
tified at sites where >1% of the reads differed from the ref-
erence genome. The presence of mutations at these sites was 
then determined by Sanger sequencing of genomic DNA 
from each thymoma. Deletions in the Notch1 locus were de-
tected as previously described (Ashworth et al., 2010), and 
deletions were sequenced by Sanger sequencing.
Quantitative rt-rcr (qrt-Pcr)
For analysis of Notch1 target gene expression in thymocytes, 
RNA was isolated using an RNeasy Mini kit, and qRT-
PCR was performed using a TaqMan RNA-to-Ct 1-Step kit 
(Thermo Fisher Scientific). The TaqMan assays used for the 
quantitation of each mRNA were Hes1 Mm01342805_m1, 
Dtx1 Mm00492297_m1, and Myc Mm00487804_m1. Gene 
expression was normalized to the expression of the house-
keeping gene Polr2a (Mm00839493_m1).
In vitro lymphocyte differentiation cultures
To evaluate B cell lineage potential, cells were sorted onto 
a monolayer of OP9 stromal cells in OP9 medium (Opti-
MEM medium with GlutaMAX [Thermo Fisher Scientific] 
with 10% FCS and 0.5 mM 2-mercaptoethanol) with 25 ng/
ml mouse Flt3 ligand, 25 ng/ml mouse SCF, and 20 ng/ml 
mouse IL-7. Medium and cytokines were changed after 7 d, 
and B cell potential was evaluated by flow cytometry after 
14 d of culture. Single cells that formed cultures containing 
at least 10 B220+ CD19+ cells were determined to have B 
cell potential. To analyze the rate of B cell differentiation, a 
portion of each culture was taken for flow cytometric analysis 
daily, and this volume was replaced by OP9 medium with cy-
tokines. To evaluate T cell lineage potential, cells were sorted 
onto a monolayer of OP9-DL1 cells in OP9 medium with 
50 ng/ml mouse Flt3 ligand, 25 ng/ml mouse SCF, and 20 
ng/ml mouse IL-7. Medium and cytokines were changed 
weekly, and T cell potential was evaluated after 21 d of cul-
ture. Single cells that formed cultures containing at least 10 
Thy1.2+ CD25+ and/or CD4+ CD8+ cells were determined 
to have T cell potential.
single-cell qrt-Pcr
Single-cell gene expression analysis was performed using 
48.48 Dynamic Array integrated fluidics chips (M48; Flu-
idigm) on the BioMark HD platform (Fluidigm) as previ-
ously described (Moignard et al., 2013). TaqMan assays (Life 
Technologies) used are listed in Table S1. To measure expres-
sion of sterile IgH, a custom probe set was used, as previously 
described (Zandi et al., 2008). Raw CT values are given in 
Table S4. Dimensionality reduction was applied to the sin-
gle-cell qRT-PCR data with both genotypes analyzed to-
gether. First, amplification curves with a quality score <0.5 
were treated as failed reactions. Gene expression was then 
normalized on a cellwise basis to the housekeeping gene 
Polr2a. A ΔCt value of −12 was assigned where a gene was 
not detected. Housekeeping genes Ubc and Polr2a, along 
with two genes not expressed in any cells (Cd3e and Ptcra), 
were excluded from further analysis. Diffusion map dimen-
sionality reduction (Coifman et al., 2005; Haghverdi et al., 
2015) was performed using the destiny R package (Angerer 
et al., 2016) with centered cosine distance and sigma = 0.5. 
Pseudotime values were assigned to single cells by applying 
the Wanderlust algorithm (Bendall et al., 2014) to coordi-
nates of cells in diffusion components 1 and 2, which were 
selected on the basis of the magnitudes of their correspond-
ing eigenvalues. To identify genes with expression related to 
differentiation of HSCs toward BLPs, cells were split into 
100 bins of equal length in pseudotime. For each gene, the 
Spearman’s rank correlation coefficient of the proportion 
of cells in a bin expressing the gene and the position of the 
bin in pseudotime was calculated using the cor.test func-
tion in R. Genes showing significant positive correlation 
with pseudotime values (Benjamini-Hochberg adjusted 
P < 0.05) were identified.
rnA-seq of populations of sorted cells
100 cells were FACS-sorted into 4 µl lysis buffer (0.2% [vol/
vol\ Triton X-100 and 1 U/µl RNase inhibitor [Clontech]). 
RNA-seq libraries were prepared from five replicates of 
each cell type using the Smart-seq2 protocol (Picelli et al., 
2013) and sequenced on an Illumina HiSeq 2500. Reads 
were aligned to the mouse genome using STAR (Dobin 
et al., 2013). The number of reads aligning to each gene 
were counted using HTSeq (Anders et al., 2015), and dif-
ferential gene expression was analyzed using the R package 
DESeq2 (Love et al., 2014). Principal component analysis 
was performed using the prcomp function in R. Gene set 
enrichment analysis was performed using the R package 
DOSE (Yu et al., 2015).
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single-cell rnA-seq
Single-cell RNA-seq libraries were generated and se-
quenced from single sorted cells as previously described 
(Wilson et al., 2015). Sequencing reads were aligned to the 
mouse genome using G-SNAP (Wu and Nacu, 2010), and 
mapped reads were assigned to Ensembl genes (release 81; 
Yates et al., 2016) by using HTSeq (Anders et al., 2015). 
Cells with >15% of mapped reads mapping to mitochondrial 
genes, <200,000 reads mapping to nuclear genes, >40% of 
mapped reads mapping to ERCC spike-ins, or <1,000 genes 
with least 10 reads in the cell mapping to that gene were 
filtered out during quality control. 183 of 192 LMPP, 227 
of 336, ALP and 140 of 144 BLP cells passed this quality 
control. Normalization size factors were computed using the 
scran R package (Lun et al., 2016), and 4,213 genes with 
variance exceeding technical levels were identified follow-
ing the method of Brennecke et al. (2013). Differential gene 
expression analysis between populations of single cells was 
performed using the edgeR package (Robinson et al., 2010). 
Diffusion map dimensionality reduction was performed 
using the destiny R package (Haghverdi et al., 2015). Dif-
fusion map embedding was calculated for both Mbd3ΔH/ΔH 
and control cells together, and the two conditions were 
then plotted separately.
AtAc-seq chromatin accessibility analysis
ATAC-seq libraries were prepared from 500 sorted cells 
as previously described (Buenrostro et al., 2013). Libraries 
underwent paired-end sequencing (2 × 125 nt) on an Illumina 
HiSeq 2500 instrument. After checking quality control with 
FastQC v.0.11.4, Nextera transposase sequence and adapter 
read-through were removed using Trimmomatic v.0.33 
(Bolger et al., 2014) in palindrome mode with parameters 
LEA DING:3 TRA ILI NG:3 SLI DIN GWI NDOW :4 :20 MIN 
LEN:35. Trimmed reads were aligned to the mouse reference 
genome using Bowtie2 v.2.2.3 (Langmead and Salzberg, 2012) 
with standard parameters except for –X 2,000 to allow for a 
maximum insert size of 2 kb. Alignment files were converted 
to Bam format with SAMtools v.1.2 (Li et al., 2009) and 
deduplicated using Picard MarkDuplicates v.1.119 (http ://
picard .sourceforge .net) with parameter REM OVE_DUP 
LIC ATES = true. Reads mapping to the mitochondrial 
genome were discarded, and alignment files were merged 
across replicates and indexed with BamTools v.2.4.0 (Barnett 
et al., 2011). ATAC-seq peaks were called using the findPeaks 
algorithm implemented in the Homer v.4.9 suite, with 
parameters –localSize 50,000 –size 150 –minDist 50 (Heinz 
et al., 2010). ATAC-seq data from Brg1-deficient mice (Bossen 
et al., 2015) were retrieved from the Short Read Archive 
(accession no. SRA246957), converted to fastq format using the 
SRA Toolkit v.2.5.4, and processed the same way we processed 
our own ATAC-seq data, with appropriate adjustments for 
single-end reads. Genomic coordinates of p300 binding sites in 
pro–B cells (Lin et al., 2012) were downloaded from the Gene 
Expression Omnibus (accession no. GSM987808) and lifted 
over to mm10 using the UCSC liftOver utility. Chd4 ChIP-
seq data in Ikzf1Δ/+ pro–B cells (Schwickert et al., 2014) were 
downloaded from NCBI SRA (accession nos. SRX398246 
and SRX398233), converted to fastq format, and aligned using 
Bowtie2. Downstream computational analyses were performed 
using R v.3.2.2 (R Core Team, 2015) and BioConductor v.3.2 
(Huber et al., 2015). Heat maps and metaprofiles of ATAC-
seq signals were computed using custom scripts and the 
Genomation package v.1.3.4 (Akalin et al., 2015).
data availability
Raw and processed data from bulk cell population RNA-
seq, single-cell RNA-seq, and ATAC-seq experiments 
have been deposited in the Gene Expression Omnibus 
(accession no. GSE101735). Raw single-cell qPCR data 
are available in Table S4.
online supplemental material
Fig. S1 shows cell counts from mouse peripheral blood, thy-
mus, and bone marrow. Fig. S2 shows the Notch1 mutations, 
and activation of Notch1 target genes, detected in Mbd3ΔH/ΔH 
T-ALLs. Fig. S3 shows that a subset of cells in Hardy fractions 
B and C from Mbd3ΔH/ΔH bone marrow express abnormally 
high levels of c-Kit. Fig. S4 shows pseudotime ordering of 
single-cell gene expression patterns, the proportion of single 
ALP cells that express genes associated with B cell differen-
tiation, and the level of Ebf1 expression in single ALPs. Fig. 
S5 shows ATAC-seq data that indicate that normal chromatin 
accessibility is normal in Mbd3ΔH/ΔH thymocytes. Table S1 
shows the assays used to measure single-cell gene expression. 
Table S2 lists the antibodies used in the study. Table S3 lists 
the oligos used for identifying point mutations in Notch1. 
Tables S4–S11 are available as Excel spreadsheets. Table S4 
provides the raw data from the single-cell qRT-PCR exper-
iment. Differential gene expression analysis is provided com-
paring Mbd3ΔH/ΔH cells to control cells from the HSC (Table 
S5), LMPP (Table S6), ALP (Table S7), and BLP (Table S8) 
populations. Table S9 provides the list of genes different be-
tween control LMPPs and BLPs, used for the dimensionality 
reduction analysis in Fig. 6 F. Table S10 provides differential 
gene expression analysis of single-cell RNA-seq data, com-
paring Mbd3ΔH/ΔH ALPs to control ALPs. Table S11 lists the 
regions of accessible chromatin detected in Mbd3ΔH/ΔH and 
control ALPs, BLPs, and pro–B cells.
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